PARKER W DOUGLAS
Known title: Chairman and CEOCIK: 0001249552
Associated companies
Transaction History
| AAL | ▼ Sell | Tax Withholding | 46,033 | $712K | 3/11/2023 | View on chart |
| AAL | ▼ Sell | Tax Withholding | 26,179 | $407K | 2/24/2023 | View on chart |
| AAL | ▼ Sell | Tax Withholding | 50,647 | $830K | 2/16/2023 | View on chart |
| AAL | ▲ Buy | Grant | 185,758 | $0 | 6/8/2022 | View on chart |
| AAL | ▲ Buy | Grant | 176,886 | $0 | 2/24/2022 | View on chart |
| AAL | ▼ Sell | Tax Withholding | 24,518 | $438K | 2/18/2022 | View on chart |
| AAL | ▼ Sell | Tax Withholding | 51,828 | $975K | 2/16/2022 | View on chart |
| AAL | ▲ Buy | Grant | 248 | $0 | 12/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Analysts Lower AAL Fair Value Amid Rising Fuel Cost Concerns
Analysts have lowered American Airlines’ fair value after reexamining fuel cost assumptions. The recent Goldman Sachs cut to an $11 target reflects the same concern. New regulatory pressure to carry epinephrine on all flights could add to operating costs, while broader airline earnings reports from Delta give context to the sector’s mixed outlook.
Analysts Lower AAL Fair Value Amid Rising Fuel Cost Concerns. Analysts have lowered American Airlines’ fair value after reexamining fuel cost assumptions. The recent Goldman Sachs cut to an $11 target reflects the same concern. New regulatory pressure to carry epinephrine on all flights could add to operating costs, while broader airline earnings reports from Delta give context to the sector’s mixed outlook.